Trials / Completed
CompletedNCT04649840
Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 274 (actual)
- Sponsor
- Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of the project: to study the dynamics of the humoral and cellular immunity in patients after pneumonia caused by the SARS-CoV-2 virus at different time intervals, in order to predict the duration of immune protection
Detailed description
* to form study groups of patients (at least 60 patients in total) who have recovered from pneumonia of varying severity caused by the SARS-CoV-2 virus (at least 30 patients in each of the groups of patients who have had pneumonia in moderate and severe forms); * to investigate the parameters of cellular immunity (the content of antigen-specific T-cells to the main viral antigens - proteins S, N, M) in patients of different groups included in the trials, in dynamics 3, 6, 9 and 12 months after the COVID-19-associated pneumonia; * to investigate the indicators of humoral immunity (the content of IgG to the main viral antigens - proteins S, N, M) in patients of different groups included in the trials, in dynamics 3, 6, 9 and 12 months after the COVID-19-associated pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Humoral and cellular immunity | Humoral (IgG) and cellular (antigen-specific cells) immunity |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-12-09
- Completion
- 2021-12-09
- First posted
- 2020-12-02
- Last updated
- 2021-12-10
Locations
1 site across 1 country: Belarus
Source: ClinicalTrials.gov record NCT04649840. Inclusion in this directory is not an endorsement.